Journal of General Virology, Vol 79, 2405-2410, Copyright © 1998 by Society for General Microbiology

ARTICLES

The Semliki Forest virus vector induces p53-independent apoptosis

GM Glasgow, MM McGee, CJ Tarbatt, DA Mooney, BJ Sheahan and GJ Atkins
Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin, Ireland.

Three deletion mutants of the structural protein region of the Semliki Forest virus (SFV) genome, including one which encompassed all the viral structural protein genes, induced apoptosis in BHK cells at 48 h after transfection, as shown by DNA laddering and TUNEL staining, as did the wild-type SFV4 RNA. A similar result was obtained for the SFV1 expression vector, which has a multicloning site inserted in place of the structural protein genes. However, in cells transfected with viral RNA containing a deletion of the nsP2 gene, neither viral RNA synthesis nor the induction of apoptosis occurred. Both SFV1 vector and wild-type SFV4 RNA induced apoptosis in human H358a lung carcinoma cells, which have a homozygous deletion of the p53 gene. It is concluded that the SFV vector encodes a function in the nonstructural coding region which induces p53-independent apoptosis and is dependent on viral RNA synthesis.

This article has been cited by other articles:

				P. Targett-Adams, G. Hope, S. Boulant, and J. McLauchlan Maturation of Hepatitis C Virus Core Protein by Signal Peptide Peptidase Is Required for Virus Production J. Biol. Chem., June 13, 2008; 283(24): 16850 - 16859. [Abstract] [Full Text] [PDF]

				S. Boulant, P. Targett-Adams, and J. McLauchlan Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus J. Gen. Virol., August 1, 2007; 88(8): 2204 - 2213. [Abstract] [Full Text] [PDF]

				M. J.V. Vaha-Koskela, J. P. Kallio, L. C. Jansson, J. E. Heikkila, V. A. Zakhartchenko, M. A. Kallajoki, V.-M. Kahari, and A. E. Hinkkanen Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice. Cancer Res., July 15, 2006; 66(14): 7185 - 7194. [Abstract] [Full Text] [PDF]

				M. Guan, J. R. Rodriguez-Madoz, P. Alzuguren, C. Gomar, M. G. Kramer, S. Kochanek, J. Prieto, C. Smerdou, and C. Qian Increased Efficacy and Safety in the Treatment of Experimental Liver Cancer with a Novel Adenovirus-Alphavirus Hybrid Vector Cancer Res., February 1, 2006; 66(3): 1620 - 1629. [Abstract] [Full Text] [PDF]

				M. Chen, C. Barnfield, T. I. Naslund, M. N. Fleeton, and P. Liljestrom MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells J. Virol., March 1, 2005; 79(5): 2964 - 2972. [Abstract] [Full Text] [PDF]

				C. Rheme, M. U. Ehrengruber, and D. Grandgirard Alphaviral cytotoxicity and its implication in vector development Exp Physiol, January 1, 2005; 90(1): 45 - 52. [Abstract] [Full Text] [PDF]

				L. M. Domegan and G. J. Atkins Apoptosis induction by the Therien and vaccine RA27/3 strains of rubella virus causes depletion of oligodendrocytes from rat neural cell cultures J. Gen. Virol., September 1, 2002; 83(9): 2135 - 2143. [Abstract] [Full Text] [PDF]

				M. N. Fleeton, P. Liljeström, B. J. Sheahan, and G. J. Atkins Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine J. Gen. Virol., March 1, 2000; 81(3): 749 - 758. [Abstract] [Full Text]

				W. W. Leitner, H. Ying, D. A. Driver, T. W. Dubensky, and N. P. Restifo Enhancement of Tumor-specific Immune Response with Plasmid DNA Replicon Vectors Cancer Res., January 1, 2000; 60(1): 51 - 55. [Abstract] [Full Text]

				G. J. Atkins, B. J. Sheahan, and P. Liljeström The molecular pathogenesis of Semliki Forest virus: a model virus made useful? J. Gen. Virol., September 1, 1999; 80(9): 2287 - 2297. [Full Text]

				M. Fleeton, B. Sheahan, E. Gould, G. Atkins, and P Liljestrom Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge J. Gen. Virol., May 1, 1999; 80(5): 1189 - 1198. [Abstract]